Search Results

Filter
  • 1-10 of  2,173 results for ""NEOVASCULARIZATION inhibitors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POOR VISUAL ACUITY.

  • Authors : Song JS; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Ophthalmology, Armed Forces Capital Hospital, Seongnam, Korea

Subjects: Visual Acuity*/Visual Acuity*/Visual Acuity*/physiology ; Intravitreal Injections* ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage

  • Source: Retina (Philadelphia, Pa.) [Retina] 2024 Sep 01; Vol. 44 (9), pp. 1486-1494.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

LONG-TERM VISUAL OUTCOMES AND OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION FOLLOWING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.

  • Authors : Viggiano P; Department of Translational Biomedicine Neuroscience, University of Bari 'Aldo Moro,' Bari, Italy.; Bisceglia G

Subjects: Tomography, Optical Coherence*/Tomography, Optical Coherence*/Tomography, Optical Coherence*/methods ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/drug therapy ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/complications

  • Source: Retina (Philadelphia, Pa.) [Retina] 2024 Sep 01; Vol. 44 (9), pp. 1572-1579.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The effect of intravitreal anti-VEGF injections on choroidal vascular index in patients with diabetic macular edema.

  • Authors : Toprak A; Kırıkhan State Hospital, Kırıkhan, Hatay, Turkey.; Koc H

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Intravitreal Injections* ; Bevacizumab*/Bevacizumab*/Bevacizumab*/administration & dosage

  • Source: Cutaneous and ocular toxicology [Cutan Ocul Toxicol] 2024 Sep; Vol. 43 (3), pp. 204-210. Date of Electronic Publication: 2024 Jul 19.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101266892 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Incidence of Blepharoptosis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

  • Authors : Lee AY; From the Department of Ophthalmology (A.Y.L., K.K., A.O., S.K., D.J.D., K.L.S., G.J.L., K.J.G.), Weill Cornell Medicine, New York, New York, USA.; Kovacs K

Subjects: Blepharoptosis*/Blepharoptosis*/Blepharoptosis*/chemically induced ; Blepharoptosis*/Blepharoptosis*/Blepharoptosis*/epidemiology ; Intravitreal Injections*/Intravitreal Injections*/Intravitreal Injections*/adverse effects

  • Source: American journal of ophthalmology [Am J Ophthalmol] 2024 Sep; Vol. 265, pp. 236-240. Date of Electronic Publication: 2024 Mar 08.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of anti-VEGF on retinal blood flow in diabetic mice using laser speckle flowgraphy.

  • Authors : Su ZZS; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Subjects: Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/administration & dosage ; Mice, Inbred C57BL* ; Intravitreal Injections*

  • Source: Acta ophthalmologica [Acta Ophthalmol] 2024 Sep; Vol. 102 (6), pp. e926-e934. Date of Electronic Publication: 2024 Apr 04.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

CAVITARY CHOROIDAL NEVUS SHOWING THICKNESS FLUCTUATIONS IN RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR DIABETIC MACULAR EDEMA: A CASE REPORT.

  • Authors : Bijon J; Vitreous Retina Macula Consultants of New York, New York, New York.; Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York

Subjects: Choroid Neoplasms*/Choroid Neoplasms*/Choroid Neoplasms*/drug therapy ; Choroid Neoplasms*/Choroid Neoplasms*/Choroid Neoplasms*/diagnosis ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/therapeutic use

  • Source: Retinal cases & brief reports [Retin Cases Brief Rep] 2024 Sep 01; Vol. 18 (5), pp. 593-597.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101298744 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-Vascular Endothelial Growth Factor (Anti-VEGF) for the Treatment of Type I ROP.

  • Authors : Gudu RK; Department of Pediatrics, Kalinga Institute of Medical Sciences, KIIT DU, Bhubaneswar, Odisha, India.; Das MK

Subjects: Retinopathy of Prematurity*/Retinopathy of Prematurity*/Retinopathy of Prematurity*/drug therapy ; Retinopathy of Prematurity*/Retinopathy of Prematurity*/Retinopathy of Prematurity*/therapy ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/antagonists & inhibitors

  • Source: Indian journal of pediatrics [Indian J Pediatr] 2024 Sep; Vol. 91 (9), pp. 959-960. Date of Electronic Publication: 2023 Nov 08.Publisher: Dr. K. C. Chaudhuri Foundation, co-published by Springer India Country of Publication: India NLM ID: 0417442 Publication Model: Print-Electronic

Record details

×
Academic Journal

Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome.

  • Authors : Raming K; From the Department of Ophthalmology (K.R, P.H, F.H, K.P), University of Bonn, Bonn, Germany.; Pfau M

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/therapeutic use ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage ; Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use

  • Source: American journal of ophthalmology [Am J Ophthalmol] 2024 Sep; Vol. 265, pp. 127-136. Date of Electronic Publication: 2024 Apr 12.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Association between time to treatment and outcome in branch retinal vein occlusion.

  • Authors : Kitano M; Department of Ophthalmology, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.; JR Tokyo General Hospital, 2-1-3 Yoyogi, Shibuya-ku, Tokyo, 151-8528, Japan.

Subjects: Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/drug therapy ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/diagnosis ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/physiopathology

  • Source: International ophthalmology [Int Ophthalmol] 2024 Aug 25; Vol. 44 (1), pp. 353. Date of Electronic Publication: 2024 Aug 25.Publisher: Kluwer Country of Publication: Netherlands NLM ID: 7904294 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2630

Record details

×
Academic Journal

Topical bromfenac in VEGF-driven maculopathies: topical review and meta-analysis.

  • Authors : Kulikov AN; Department of Ophthalmology, Military Medical Academy, 21, Botkinskaya str., St. Petersburg, 194044, Russia.; Vasiliev AS

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/administration & dosage ; Benzophenones*/Benzophenones*/Benzophenones*/administration & dosage

  • Source: BMC ophthalmology [BMC Ophthalmol] 2024 Aug 23; Vol. 24 (1), pp. 369. Date of Electronic Publication: 2024 Aug 23.Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415

Record details

×
  • 1-10 of  2,173 results for ""NEOVASCULARIZATION inhibitors""